IOBT Q3 2024 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$205,000

Operating Income

-$27M

Net Income

-$24M

EPS (Diluted)

$-0.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$90M

Total Liabilities

$17M

Stockholders' Equity

$73M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$205,000	-$194,000	-5.7%
Operating Income	-$27M	-$23M	-12.9%
Net Income	-$24M	-$22M	-10.8%